中文｜English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R
Volume 40 Issue 5
May  2024
Turn off MathJax
Article Contents
Article Navigation >  Journal of Clinical Hepatology  > 2024  >  40(5): 1016-1020

Effect of high-frequency irreversible electroporation in the ablation of porcine pancreatic tissue

DOI: 10.12449/JCH240523
  • 1.

    School of Medical Devices，Shanghai University of Medicine & Health Sciences，Shanghai 201318，China

  • 2.

    Department of Dermatology，Tongren Hospital，Shanghai Jiao Tong University School of Medicine，Shanghai 200336，China

  • 3.

    Department of Pancreatic Surgery，Ruijin Hospital，Shanghai Jiao Tong University School of Medicine，Shanghai 200025，China

  • 4.

    Liver Disease Center，The Affiliated Hospital of Qingdao University，Qingdao，Shandong 266003，China

Research funding:

Shandong Provincial Natural Science Foundation Project (ZR2023MH111)

More Information
  • Corresponding author: LIU Chao， liuchao2311@126.com （ORCID： 0009-0002-9203-5800）
  • Received Date: 2023-08-30
  • Accepted Date: 2023-10-27
  • Published Date: 2024-05-25
    Abstract
  •   Objective  To investigate the effect of high-frequency irreversible electroporation （H-FIRE） in the ablation of pig pancreatic tissue.  Methods  Laparotomy was conducted in this study， and needle electrodes were used to release electric pulses in 12 pigs. Three sets of parameters were established for ablation at the low， medium， and high values of field strength （1 000 V/cm， 1 500 V/cm， and 2 500 V/cm）. The groups were compared in terms of the data including postoperative recovery， ablation area， and histopathological features to validate the safety and efficacy of H-FIRE in the ablation of porcine pancreatic tissue. The paired t-test was used for comparison of continuous data between two groups.  Results  All pigs in the experiment survived and showed a good effect of ablation. The histopathological analysis of all groups showed thorough and effective ablation， with a clear boundary between the ablated area and the normal tissue area. The mean ablation area in the low， medium， and high field strength groups was 30.96±3.73 mm2， 51.93±25.26 mm2， and 108.90±55.23 mm2， respectively， and the high and medium field strength groups had a significantly larger ablation area than the low field strength group （both P<0.05）， while there was no significant difference in ablation area between the medium and high field strength groups （P>0.05）.  Conclusion  H-FIRE ablation is safe and effective for porcine pancreatic tissue under specific ablation parameters.

     

    • FullText(HTML)
  • loading
    • References(29)
  • [1]
    TORRE LA, SIEGEL RL, WARD EM, et al. Global cancer incidence and mortality rates and trends: An update[J]. Cancer Epidemiol Biomarkers Prev, 2016, 25( 1): 16- 27. DOI: 10.1158/1055-9965.EPI-15-0578.
    [2]
    KWON W, THOMAS A, KLUGER MD. Irreversible electroporation of locally advanced pancreatic cancer[J]. Semin Oncol, 2021, 48( 1): 84- 94. DOI: 10.1053/j.seminoncol.2021.02.004.
    [3]
    ZHANG ZH, HE SL, WANG P, et al. The efficacy and safety of gemcitabine-based combination therapy vs. gemcitabine alone for the treatment of advanced pancreatic cancer: A systematic review and meta-analysis[J]. J Gastrointest Oncol, 2022, 13( 4): 1967- 1980. DOI: 10.21037/jgo-22-624.
    [4]
    SPRINGFELD C, JÄGER D, BÜCHLER MW, et al. Chemotherapy for pancreatic cancer[J]. Presse Med, 2019, 48( 3 Pt 2): e159- e174. DOI: 10.1016/j.lpm.2019.02.025.
    [5]
    GEBOERS B, SCHEFFER HJ, GRAYBILL PM, et al. High-voltage electrical pulses in oncology: Irreversible electroporation, electrochemotherapy, gene electrotransfer, electrofusion, and electroimmunotherapy[J]. Radiology, 2020, 295( 2): 254- 272. DOI: 10.1148/radiol.2020192190.
    [6]
    LIU CP, YE P, ZHANG MY. Research progress in irreversible electroporation ablation for tumors[J]. J Interv Radiol, 2023, 32( 5): 498- 502. DOI: 10.3969/j.issn.1008-794X.2023.05.018.

    刘春苹, 叶萍, 张明悦. 不可逆电穿孔对肿瘤消融的研究进展[J]. 介入放射学杂志, 2023, 32( 5): 498- 502. DOI: 10.3969/j.issn.1008-794X.2023.05.018.
    [7]
    GARCIA PA, KOS B, ROSSMEISL JH Jr, et al. Predictive therapeutic planning for irreversible electroporation treatment of spontaneous malignant glioma[J]. Med Phys, 2017, 44( 9): 4968- 4980. DOI: 10.1002/mp.12401.
    [8]
    LATOUCHE EL, SANO MB, LORENZO MF, et al. Irreversible electroporation for the ablation of pancreatic malignancies: A patient-specific methodology[J]. J Surg Oncol, 2017, 115( 6): 711- 717. DOI: 10.1002/jso.24566.
    [9]
    QASRAWI R, SILVE L, BURDÍO F, et al. Anatomically realistic simulations of liver ablation by irreversible electroporation: Impact of blood vessels on ablation volumes and undertreatment[J]. Technol Cancer Res Treat, 2017, 16( 6): 783- 792. DOI: 10.1177/1533034616687477.
    [10]
    MARTIN RC, SCHWARTZ E, ADAMS J, et al. Intra-operative anesthesia management in patients undergoing surgical irreversible electroporation of the pancreas, liver, kidney, and retroperitoneal tumors[J]. Anesth Pain Med, 2015, 5( 3): e22786. DOI: 10.5812/aapm.22786.
    [11]
    MEROLA G, FUSCO R, DI BERNARDO E, et al. Design and characterization of a minimally invasive bipolar electrode for electroporation[J]. Biology(Basel), 2020, 9( 9): 303. DOI: 10.3390/biology9090303.
    [12]
    LEE EW, SHAHROUKI P, PETERSON S, et al. Safety of irreversible electroporation ablation of the pancreas[J]. Pancreas, 2021, 50( 9): 1281- 1286. DOI: 10.1097/MPA.0000000000001916.
    [13]
    AGNASS P, van VELDHUISEN E, VOGEL JA, et al. Thermodynamic profiling during irreversible electroporation in porcine liver and pancreas: A case study series[J]. J Clin Transl Res, 2020, 5( 3): 109- 132.
    [14]
    SOROKIN I, CANVASSER N, JOHNSON B, et al. Irreversible electroporation for renal ablation does not cause significant injury to adjacent ureter or bowel in a porcine model[J]. J Endourol, 2021, 35( 6): 873- 877. DOI: 10.1089/end.2020.0856.
    [15]
    MA XY, XIAO YY, ZHANG X, et al. Comparison of irreversible electroporation with cryotherapyablation in porcine liver tissue[J]. Chin J Interv Imag Ther, 2015, 12( 5): 267- 270. DOI: 10.13929/j.1672-8475.2015.05.004.

    马旭阳, 肖越勇, 张欣, 等. 不可逆电穿孔与冷冻治疗消融猪肝脏组织对比分析[J]. 中国介入影像与治疗学, 2015, 12( 5): 267- 270. DOI: 10.13929/j.1672-8475.2015.05.004.
    [16]
    MIZRAHI JD, SURANA R, VALLE JW, et al. Pancreatic cancer[J]. Lancet, 2020, 395( 10242): 2008- 2020. DOI: 10.1016/S0140-6736(20)30974-0.
    [17]
    GUGENHEIM J, CROVETTO A, PETRUCCIANI N. Neoadjuvant therapy for pancreatic cancer[J]. Updates Surg, 2022, 74( 1): 35- 42. DOI: 10.1007/s13304-021-01186-1.
    [18]
    ZHANG BL, ZHOU FY, HONG JZ, et al. The role of FOLFIRINOX in metastatic pancreatic cancer: A meta-analysis[J]. World J Surg Oncol, 2021, 19( 1): 182. DOI: 10.1186/s12957-021-02291-6.
    [19]
    PASSARDI A, RAPPOSELLI IG, SCARPI E, et al. Multimodal treatment with GEMOX plus helical tomotherapy in unresectable locally advanced pancreatic cancer: A pooled analysis of two phase 2 studies[J]. Biomolecules, 2021, 11( 8): 1200. DOI: 10.3390/biom11081200.
    [20]
    General Office of National Health Commission. Standard for diagnosis and treatment of pancreatic cancer(2022 edition)[J]. J Clin Hepatol, 2022, 38( 5): 1006- 1030. DOI: 10.3969/j.issn.1001-5256.2022.05.007.

    国家卫生健康委办公厅. 胰腺癌诊疗指南(2022年版)[J]. 临床肝胆病杂志, 2022, 38( 5): 1006- 1030. DOI: 10.3969/j.issn.1001-5256.2022.05.007.
    [21]
    TASU JP, TOUGERON D, ROLS MP. Irreversible electroporation and electrochemotherapy in oncology: State of the art[J]. Diagn Interv Imaging, 2022, 103( 11): 499- 509. DOI: 10.1016/j.diii.2022.09.009.
    [22]
    LIANG B, NIU LZ, ZENG JY, et al. Irreversible electroporation ablation of the hepatic region close to the gallbladder: Pathological observation in experimental rabbits[J]. J Interv Radiol, 2014, 23( 4): 320- 324. DOI: 10.3969/j.issn.1008-794X.2014.04.012.

    梁冰, 牛立志, 曾健滢, 等. 不可逆电穿孔消融兔胆囊侧肝脏病理学观察[J]. 介入放射学杂志, 2014, 23( 4): 320- 324. DOI: 10.3969/j.issn.1008-794X.2014.04.012.
    [23]
    NIU LZ, ZENG JY, ZHANG YS, et al. Irreversible electroporation ablation therapy for pancreatic adenocarcinoma: Observation of its safety and short-term effect[J]. J Interv Radiol, 2016, 25( 3): 225- 230.

    牛立志, 曾健滢, 张怡湜, 等. 不可逆电穿孔消融治疗胰腺癌的安全性及近期疗效观察[J]. 介入放射学杂志, 2016, 25( 3): 225- 230.
    [24]
    MEIJERINK MR, RUARUS AH, VROOMEN LGPH, et al. Irreversible electroporation to treat unresectable colorectal liver metastases(COLDFIRE-2): A phase II, two-center, single-arm clinical trial[J]. Radiology, 2021, 299( 2): 470- 480. DOI: 10.1148/radiol.2021203089.
    [25]
    RUARUS AH, VROOMEN LGPH, GEBOERS B, et al. Percutaneous irreversible electroporation in locally advanced and recurrent pancreatic cancer(PANFIRE-2): A multicenter, prospective, single-arm, phase II study[J]. Radiology, 2020, 294( 1): 212- 220. DOI: 10.1148/radiol.2019191109.
    [26]
    WAH TM, LENTON J, SMITH J, et al. Irreversible electroporation(IRE) in renal cell carcinoma(RCC): A mid-term clinical experience[J]. Eur Radiol, 2021, 31( 10): 7491- 7499. DOI: 10.1007/s00330-021-07846-5.
    [27]
    WANG HF, XUE W, YAN WG, et al. Extended focal ablation of localized prostate cancer with high-frequency irreversible electroporation: A nonrandomized controlled trial[J]. JAMA Surg, 2022, 157( 8): 693- 700. DOI: 10.1001/jamasurg.2022.2230.
    [28]
    Chinese Society of Interventional and Minimally Invasive Therapy, China Medicine Education Association. Expert consensus on image-guided irreversible electroporation ablation for pancreatic cancer(2018)[J]. J Clin Hepatol, 2019, 35( 2): 299- 302. DOI: 10.3969/j.issn.1001-5256.2019.02.011.

    中国医药教育协会介入微创治疗专业委员会. 影像学引导胰腺癌不可逆电穿孔消融治疗专家共识2018版[J]. 临床肝胆病杂志, 2019, 35( 2): 299- 302. DOI: 10.3969/j.issn.1001-5256.2019.02.011.
    [29]
    RASHID MF, HECHT EM, STEINMAN JA, et al. Irreversible electroporation of pancreatic adenocarcinoma: a primer for the radiologist[J]. Abdom Radiol(NY), 2018, 43( 2): 457- 466. DOI: 10.1007/s00261-017-1349-3.
    • Relative Articles
    • Supplements(0)
    • Cited By
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Figures(4)  / Tables(1)

    Get Citation
    PDF
    XML

    Article Metrics

    Article views (129) PDF downloads(17) Cited by()
    Proportional views
    Related
        

    The first journal specializing in hepatobiliary and pancreatic diseases in China

    Supervisor：Ministry of Education of the People's Republic of China

    Sponsor：Jilin University

    Academic Support: Chinese Society of Hepatology，Chinese Medical Association

    Address: 461 Xinjiang Road, Changchun

    Submit：0431-88782044

    Peer review：0431-88783542

    Email：lcgdb@vip.163.com

    About Journal

    Submission Guideline

    Journal Online

    Hepatobiliary College

    Guidelines

    YesterdayIP[]YesterdayPV[]TodayIP[]TodayPV[]Online[]

    Website Design © 2020 Editorial Board of Journal of Clinical Hepatology 吉ICP备10000617号-1 Supported by: Beijing Renhe Information Technology Co. Ltd  

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return